Drug-induced hepatitis
Shimizu, Y.; Asada, T.; Nishikawa, H.; Iwane, Y.; Hamatani, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 8): 538-544
2007
ISSN/ISBN: 0047-1852 PMID: 18074598 Document Number: 609403
Document emailed within 1 workday
Related Documents
Koriakin, V.A.; Sokolova, G.B.; Ziia, A.V.; Zeliger, L.R.; Ivleva, A.Ia. 1987: Pharmacokinetic bases for the drug-free prevention of drug-induced hepatitis in pulmonary tuberculosis patients Terapevticheskii Arkhiv 59(7): 75-77Vial, T.; Descotes, J. 1993: Drug-induced granulomatous hepatitis Gastroenterologie Clinique et Biologique 17(5 Part 2): H44-H48
Polunina, T.E. 1989: Acute drug-induced hepatitis Klinicheskaia Meditsina 67(10): 87-90
Labayle, D.; Lenoir, C.; Buffet, C.; Chaput, J.C.; Etienne, P. 1979: Drug-induced active hepatitis La Nouvelle Presse Medicale 8(24): 2013-2015
Cales, P.; Perpere, J.; Trocard, J.; Pienkowkski, P.; Ravaud, A.; Voigt, J.J.; Vinel, J.P.; Pascal, J.P. 1986: Gallbladder collapse in drug-induced hepatitis Presse Medicale 15(26): 1244
Neri, S.; Balsamo, D.; Calvagno, G.S.; Gangemi, P.; Astuto, M.; Altadonna, F. 2003: A rare case of drug-induced hepatitis Minerva Gastroenterologica E Dietologica 49(2): 155-158
Wada, M. 2005: Anti-tuberculosis drug-induced hepatitis Kekkaku: 80(9): 607-611
Machnik, G.; Bergert, A.; Justus, J.; Kunze, P.; Müller, R.; Reinhardt, M.; Schulz, H.; Stein, G.; Thiele, R. 1988: Drug-induced hepatitis after dihydralazine treatment with fatal consequences Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 134(2): 167-177
Ivlev, A.S.; Polunina, T.E. 1988: Severe acute drug-induced hepatitis in a patient with benign hyperbilirubinemia of the Gilbert type Klinicheskaia Meditsina 66(2): 137-138
Buwa, S.; Patil, S.; Kulkarni, P.H.; Kanase, A. 2001: Hepatoprotective action of abhrak bhasma, an ayurvedic drug in albino rats against hepatitis induced by CCl4 Indian Journal of Experimental Biology 39(10): 1022-1027
Greminger, S. 1997: Massive increase in transaminases and thrombocytopenia. Acute drug-induced toxic hepatitis (probable culprit: paracetamol) Praxis 86(38): 1476-1477
Courcambeck, J.ér.ôm.; Bouzidi, M.; Perbost, R.ég.; Jouirou, B.; Amrani, N.; Cacoub, P.; Pèpe, G.ér.; Sabatier, J.-M.; Halfon, P. 2006: Resistance of hepatitis C virus to NS3-4A protease inhibitors: mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations Antiviral Therapy 11(7): 847-855
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Nasir, A.; Todd, C.S.; Stanekzai, M.R.; Bautista, C.T.; Botros, B.A.; Scott, P.T.; Strathdee, S.A.; Tjaden, J. 2011: Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities International Journal on Drug Policy 22(2): 145-152
Azarkar, Z.; Sharifzadeh, G. 2010: Evaluation of the Prevalence of Hepatitis B, Hepatitis C, and HIV in Inmates with Drug-Related Convictions in Birjand, Iran in 2008 Hepatitis Monthly 10(1): 26-30
Will, T. 1999: Early decline in an epidemic: evolution of the prevalences of HIV, hepatitis B, hepatitis C and aminotransferases in intravenous drug abusers in Strasbourg between 1980 and 1990 Revue Medicale de la Suisse Romande 119(4): 329-334
Oliveira, S.A.N.; Hacker, M.A.; Oliveira, M.L.A.; Yoshida, C.F.T.; Telles, P.R.; Bastos, F.I. 2005: A window of opportunity: declining rates of hepatitis B virus infection among injection drug users in Rio de Janeiro, and prospects for targeted hepatitis B vaccination Revista Panamericana de Salud Publica 18(4-5): 271-277
Shapiro, I.I.; Shabrov, A.V.; Karev, V.E.; Leenman, E.E.; Kvetnoĭ, I.M.; Tsinzerling, V.A.; Sologub, T.V. 2005: Clinical and molecular correlation between chronic hepatitis and hepatocellular carcinoma induced by hepatitis B virus Arkhiv Patologii 67(2): 6-10
Jarrett, W.F.; O'Neil, B.W.; Lindholm, I. 1987: Persistent hepatitis and chronic fibrosis induced by canine acidophil cell hepatitis virus Veterinary Record 120(10): 234-235
Sunthornchart, S.; Linkins, R.W.; Natephisarnwanish, V.; Levine, W.C.; Maneesinthu, K.; Lolekha, R.; Tappero, J.W.; Trirat, N.; Muktier, S.; Chancharastong, P.; Fox, K.; Donchalermpak, S.; Vitek, C.; Supawitkul, S. 2008: Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005 Addiction 103(10): 1687-1695